WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Sees Large Volume Increase – What’s Next?

Posted by Casey Walker on Sep 19th, 2026

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) saw unusually-high trading volume on Thursday . 256,992 shares traded hands during trading, an increase of 265% from the previous session’s volume of 70,444 shares.The stock last traded at $12.30 and had previously closed at $12.54.

Analysts Set New Price Targets

Separately, Zacks Research upgraded WuXi Biologics (Cayman) to a “hold” rating in a report on Friday, August 28th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company presently has a consensus rating of “Hold”.

Read Our Latest Analysis on WXXWY

WuXi Biologics (Cayman) Stock Performance

The business has a 50-day moving average price of $11.44 and a two-hundred day moving average price of $9.62.

WuXi Biologics (Cayman) Company Profile

(Get Free Report)

WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.

Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.